BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Moponetug readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Moponetug\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06268886-688@assetmemo.bio
DTSTAMP:20261121T004537Z
DTSTART;VALUE=DATE:20261217
DTEND;VALUE=DATE:20261218
SUMMARY:Moponetug: Phase 2 readout est. (NCT06268886)
DESCRIPTION:Moponetug\, phase 2\, Alzheimer's Disease.\nStudy: Study to Eva
 luate the Efficacy\, Safety\, and Tolerability of an Anti-MTBR Tau Monoclo
 nal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease\n
 Estimated primary completion: 17 December 2026. This is a ClinicalTrials.g
 ov estimate\, not a confirmed readout date\, and it can move.\nDrug page: 
 https://assetmemo.bio/drug/moponetug#upcoming-events\nRegistry record: htt
 ps://clinicaltrials.gov/study/NCT06268886
URL:https://assetmemo.bio/drug/moponetug#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07780383-688@assetmemo.bio
DTSTAMP:20261121T004537Z
DTSTART;VALUE=DATE:20270617
DTEND;VALUE=DATE:20270618
SUMMARY:Moponetug: Phase 1 readout est. (NCT07780383)
DESCRIPTION:Moponetug\, phase 1\, Alzheimer's Disease.\nStudy: A Study to E
 valuate the Drug Levels\, Absolute Bioavailability\, Safety\, Tolerability
 \, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After
  Single-dose Administration\, and Participants With Early Alzheimer's Dise
 ase After Multiple Dose Administration\nEstimated primary completion: 17 J
 une 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/moponetug#u
 pcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07780
 383
URL:https://assetmemo.bio/drug/moponetug#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07852962-688@assetmemo.bio
DTSTAMP:20261121T004537Z
DTSTART;VALUE=DATE:20270718
DTEND;VALUE=DATE:20270719
SUMMARY:Moponetug: Phase 1 readout est. (NCT07852962)
DESCRIPTION:Moponetug\, phase 1.\nStudy: Study to Assess Drug Levels\, Immu
 ne Response\, Safety and Tolerability of BMS-986446 in Healthy Chinese Par
 ticipants.\nEstimated primary completion: 18 July 2027. This is a Clinical
 Trials.gov estimate\, not a confirmed readout date\, and it can move.\nDru
 g page: https://assetmemo.bio/drug/moponetug#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07852962
URL:https://assetmemo.bio/drug/moponetug#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
